leisure time -WSS

leisure time

author：focus 2025-09-27 12:57:09 - browse：6

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Diabetes management: Digital health tools fall short, study says

WSS

Mirador, a new biotech startup, launches with $400 million

How generative AI is inspiring dreams of a health data revolution

What Kate Middleton's cancer revelation might teach the world

This gene therapy has record $4.25 million price. It's saved children.

Adam's Take: Intra

Crinetics acromegaly drug succeeds in late

Wikipedia

leisure time

focus

At least 13 dead in Texas as scorching temps continue

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Bright Health sells Medicare Advantage business to Molina

NIH nominee Bertagnolli will get October confirmation hearing

As demand for Covid shots wanes, Moderna seeks its next success

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

As demand for Covid shots wanes, Moderna seeks its next success

Diabetes management: Digital health tools fall short, study says

In age of alternative facts, a scholarly course on calling out crap

Steward Health Care expansion into Malta flopped

hotspot

Asbestos ban is immediate, but health effects will linger for decades

Adam's Take: Intra

This gene therapy has record $4.25 million price. It's saved children.

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Asbestos ban is immediate, but health effects will linger for decades

A rare thyroid diagnosis led to unexpected, all

hotspot

Wikipedia

hotspot

leisure time